20 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33610557 | Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium. | 2021 Apr 16 | 3 |
2 | 34015214 | Ellagic Acid Inhibits α-Synuclein Aggregation at Multiple Stages and Reduces Its Cytotoxicity. | 2021 Jun 2 | 1 |
3 | 34046949 | Polyphenol-solubility alters amyloid fibril formation of α-synuclein. | 2021 Aug | 1 |
4 | 34948195 | Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy. | 2021 Dec 13 | 1 |
5 | 32822152 | Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies. | 2020 Oct 7 | 1 |
6 | 33185419 | Polyphenol Honokiol and Flavone 2',3',4'-Trihydroxyflavone Differentially Interact with α-Synuclein at Distinct Phases of Aggregation. | 2020 Dec 16 | 2 |
7 | 33186020 | Epigallocatechin Gallate Destabilizes α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface. | 2020 Dec 16 | 1 |
8 | 29976995 | Sir-2.1 mediated attenuation of α-synuclein expression by Alaskan bog blueberry polyphenols in a transgenic model of Caenorhabditis elegans. | 2018 Jul 5 | 1 |
9 | 26517049 | Modulating the Amyloidogenesis of α-Synuclein. | 2016 | 1 |
10 | 25498223 | Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys. | 2015 Feb 12 | 1 |
11 | 24835632 | Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity. | 2014 Jul 15 | 1 |
12 | 23064431 | Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein. | 2013 Jan | 2 |
13 | 21966584 | In vitro recapitulation of aberrant protein inclusions in neurodegenerative diseases: New cellular models of neurodegenerative diseases. | 2011 Jul | 1 |
14 | 19895818 | Characterization of inhibitor-bound alpha-synuclein dimer: role of alpha-synuclein N-terminal region in dimerization and inhibitor binding. | 2010 Jan 22 | 1 |
15 | 20385841 | EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. | 2010 Apr 27 | 1 |
16 | 20801100 | Amyloid formation and disaggregation of α-synuclein and its tandem repeat (α-TR). | 2010 Oct 1 | 1 |
17 | 19183551 | Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies. | 2009 Feb 18 | 1 |
18 | 19616561 | (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway. | 2009 Sep 25 | 1 |
19 | 18511942 | EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. | 2008 Jun | 1 |
20 | 16681381 | Small molecule inhibitors of alpha-synuclein filament assembly. | 2006 May 16 | 1 |